summit clinical trial tirzepatide SUMMIT: Improves Outcomes and Quality of Life For Patients With HFpEF and Obesity 408. Journal Club: The SUMMIT

This article is part of the PlexusDx Education Hub evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic variables behind every metabolic decision

Poor diet, environmental pollutants, and lack of sleep can also drain our reserves

Overall, it appears that overweight, obese, and/or diabetic research subjects have better results than normal-weight subjects when using a GLP-1 medication to treat a substance use disorder (Marquez-Meneses, 2025)

Medical Supervision Matters When it comes to weight loss medications, medical supervision is key

You may request a pat-down as an alternative to imaging